IDL Diagnostics AB (publ) (STO:IDLDX)
Sweden · Delayed Price · Currency is SEK 0.4300
+0.0240 (5.91%)
Jul 31, 2026, 4:59 PM CET
IDL Diagnostics AB Market Cap
IDL Diagnostics AB has a market cap or net worth of 99.06 million as of July 31, 2026. Its market cap has decreased by -24.30% in one year.
Market Cap
99.06M
Enterprise Value
74.41M
Revenue
54.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.43
ChartMarket Cap Chart
Since May 25, 2011, IDL Diagnostics AB's market cap has increased from 16.78M to 99.06M, an increase of 490.39%. That is a compound annual growth rate of 12.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 99.06M | 21.81% |
| Dec 30, 2025 | 81.32M | -9.49% |
| Dec 30, 2024 | 89.84M | -10.76% |
| Dec 29, 2023 | 100.67M | -29.52% |
| Dec 30, 2022 | 142.82M | 31.17% |
| Dec 30, 2021 | 108.88M | -38.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 164.34B |
| Getinge AB | 64.85B |
| Sectra AB | 54.56B |
| Camurus AB | 37.22B |
| Immunovia AB | 120.00M |
| Arcoma AB | 115.04M |
| OncoZenge AB | 97.07M |
| Iconovo AB | 96.17M |